List Title | APhA DrugInfoLine

Cardiology

SORT BY: Most Recent Most Viewed

March 1, 2001

ACE Inhibitors in Atherosclerosis and Diabetes: Just Use Them

READ

PREVIEW
Unless contraindicated or not tolerated, ACE inhibitors should be considered for all patients with atherosclerosis and/or diabetes. Even patients who show evidence of insulin resistance but who...
January 1, 2001

ACE Inhibitors in Heart Failure: High Standard Doses May Be Enough

READ

PREVIEW
The common practice of pushing doses of ACE inhibitors beyond customary amounts in patients with established congestive heart failure (CHF) may be unnecessary, if results of one clinical study...
January 1, 2001

Abciximab Bests Tirofiban in Head-to-Head PCI Trial

READ

PREVIEW
For percutaneous coronary interventions (PCI), abciximab (ReoPro—Lilly) provided superior clinical outcomes when tested versus tirofiban (Aggrastat—Merck) in a direct comparison of...
November 1, 2000

LDL-C: Treatment Beyond Goal Not Yet Evidence-Based

READ

PREVIEW
“The lower the better” is not necessarily a valid assumption when it comes to treating patients with hypercholesterolemia and elevated LDL-C levels. Treating patients to LDL-C levels...
November 1, 2000

Omapatrilat: Balancing Risks, Benefits in Severe Congestive Heart Failure

READ

PREVIEW
Evidence is growing that vasopeptidase inhibition—as provided by the investigational agent omapatrilat (Vanlev—Bristol-Myers Squibb)—adds an important element in treatment of...

Pages

Medication Monitor

RSS Follow Medication Monitor on Twitter Follow APhA Druginfoline on Twitter

2215 Constitution Avenue NW, Washington, DC 20037 Telephone 202-628-4410 Fax 202-783-2351

© 2013 American Pharmacists Association All Rights Reserved.

About the American
Pharmacists Association

The American Pharmacists Association (APhA) is the organization whose members are recognized in society as essential in all patient care settings for optimal medication use that improves health, wellness and quality of life. Through information, education and advocacy, APhA empowers its members to improve medication use and advance patient care.

About APhA DrugInfoLine

APhA DrugInfoLine (ISSN 2162-3015) is a weekly publication of, and is owned and copyrighted by the American Pharmacists Association, the national professional society of pharmacists. Materials in APhA DrugInfoLine do not neccessarily represent the policy, recommendations, or endorsement of APhA. The publisher, authors, editors, reviewers, and contributors have taken care to ensure that the information contained in APhA DrugInfoLine is accurate and current; however, they shall have no ability to any person or entity with regard to claims, losses, or damage caused or alleged to be caused, directly or indirectly by use of any information contained in the publication. All decisions about drug therapy must be based on independent judgement of the clinician.